JPRN-UMIN000049408已完成Unknown
Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products - Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products
Akishima Clinic0 个研究点目标入组 35 人开始时间: 2022年11月2日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •eGFR: less than 45 mL/min/1.73 m2
研究者
相似试验
终止
不适用
Combination of SGLT2 inhibitor and DPP-4 inhibitor as add-on therapy in subjects with type 2 diabetes inadequately controlled on insulin combined with metformin + DPP-4 inhibitor or metformin + SGLT2 inhibitor or metformin : open-label, multicenter trialKCT0004959Korea University Anam Hospital102
已完成
不适用
Comparison of SGLT2 inhibitors versus DPP-4 inhibitors for diabetic macular edemaType 2 diabetes mellitusJPRN-UMIN000015873Yokohama City University Medical Center30
尚未招募
不适用
SGLT2 inhibitor versus DPP-4 inhibitor on left ventricular ejection fraction measured by echocardiography in diabetic patients with acute myocardial infarction and midranged ejection fraction (EMPA-MI-MREF)Diseases of the circulatory systemKCT0007622Chonnam National University Hospital600
已完成
不适用
Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemiaType 2 diabetes mellitusJPRN-UMIN000010397Yokohama City University Medical Center150
已完成
不适用
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trialType 2 diabetesJPRN-UMIN000013356St.Marianna University School of Medicine60